Literature DB >> 28839761

Investigation and management of pancreatic tumours.

Lyn A Smith1, Nigel B Jamieson2, Colin J McKay2.   

Abstract

Pancreatic cancer is the 10th most commonly diagnosed cancer in the UK and the fifth most common cause of cancer death. It remains one of the most aggressive cancers with over 95% of patients affected dying of their disease. Often presenting at an advanced stage of disease progression, there is currently no simple screening test available. Therefore a high clinical suspicion and prompt appropriate investigation is required from physicians when dealing with patients with symptoms in keeping with pancreatic cancer. The gastroenterology 2010 curriculum states that trainees should learn the presentation and multidisciplinary management of patients with pancreatic tumours. In this article we discuss the typical clinical presentations of common and less common pancreatic tumours followed by the investigation, staging and management required.

Entities:  

Keywords:  Pancreas; Pancreatic Cancer; Pancreatic Disease; Pancreatic Endocrine Tumour; Pancreatic Tumours

Year:  2013        PMID: 28839761      PMCID: PMC5369717          DOI: 10.1136/flgastro-2013-100364

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  44 in total

Review 1.  Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.

Authors:  Laurens A van der Waaij; Hendrik M van Dullemen; Robert J Porte
Journal:  Gastrointest Endosc       Date:  2005-09       Impact factor: 9.427

2.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 3.  Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  S Cascinu; S Jelic
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

4.  Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.

Authors:  Jeannelyn S Estrella; Asif Rashid; Jason B Fleming; Matthew H Katz; Jeffrey E Lee; Robert A Wolf; Gauri R Varadhachary; Peter W T Pisters; Eddie K Abdalla; Jean-Nicolas Vauthey; Hua Wang; Henry F Gomez; Douglas B Evans; James L Abbruzzese; Huamin Wang
Journal:  Cancer       Date:  2011-07-06       Impact factor: 6.860

5.  Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome.

Authors:  Jeannine Bachmann; Markus W Büchler; Helmut Friess; Marc E Martignoni
Journal:  Nutr Cancer       Date:  2013       Impact factor: 2.900

6.  Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief.

Authors:  J J Rykowski; M Hilgier
Journal:  Anesthesiology       Date:  2000-02       Impact factor: 7.892

Review 7.  ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts.

Authors:  Asif Khalid; William Brugge
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

8.  MR pancreatography: a useful tool for evaluating pancreatic disorders.

Authors:  A S Fulcher; M A Turner
Journal:  Radiographics       Date:  1999 Jan-Feb       Impact factor: 5.333

9.  Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis.

Authors:  Jian Shen; William R Brugge; Christopher J Dimaio; Martha B Pitman
Journal:  Cancer       Date:  2009-06-25       Impact factor: 6.860

10.  Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis.

Authors:  J Everhart; D Wright
Journal:  JAMA       Date:  1995 May 24-31       Impact factor: 56.272

View more
  1 in total

Review 1.  Determining Optimal Routes to Surgery for Borderline Resectable Venous Pancreatic Cancer-Where Is the Least Harm and Most Benefit?

Authors:  Rupaly Pandé; Keith J Roberts
Journal:  Front Oncol       Date:  2019-10-17       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.